Abstract:Summary Antibodies provide an essential layer of protection from infection and reinfection with microbial pathogens. An impaired ability to produce antibodies results in immunodeficiency and necessitates the constant substitution with pooled serum antibodies from healthy donors. Among the five antibody isotypes in humans and mice, immunoglobulin G (IgG) antibodies are the most potent anti‐microbial antibody isotype due to their long half‐life, their ability to penetrate almost all tissues and due to their ability to trigger a wide variety of effector functions. Of note, individuals suffering from IgG deficiency frequently produce self‐reactive antibodies, suggesting that a normal serum IgG level also may contribute to maintaining self‐tolerance. Indeed, the substitution of immunodeficient patients with pooled serum IgG fractions from healthy donors, also referred to as intravenous immunoglobulin G (IVIg) therapy, not only protects the patient from infection but also diminishes autoantibody induced pathology, providing more direct evidence that IgG antibodies play an active role in maintaining tolerance during the steady state and during resolution of inflammation. The aim of this review is to discuss different conceptual models that may explain how serum IgG or IVIg can contribute to maintaining a balanced immune response. We will focus on pathways depending on the IgG fragment crystallizable (Fc) as pre‐clinical data in various mouse model systems as well as human clinical data have demonstrated that the IgG Fc‐domain recapitulates the ability of intact IVIg with respect to its ability to trigger resolution of inflammation. We will further discuss how the findings already have or are in the process of being translated to novel therapeutic approaches to substitute IVIg in treating autoimmune inflammation.

Recent advances in the molecular understanding of immunoglobulin A

Rethinking mucosal antibody responses: IgM, IgG and IgD join IgA

Role of Polymeric Immunoglobulin Receptor in IgA and IgM Transcytosis

The Effects of Secretory IgA in the Mucosal Immune System

Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut

Role of cellular effectors in the induction and maintenance of IgA responses leading to protective immunity against enteric bacterial pathogens

IgA and FcαRI: Versatile Players in Homeostasis, Infection, and Autoimmunity

IgA and the intestinal microbiota: the importance of being specific

Unmasking the potential of secretory IgA and its pivotal role in protection from respiratory viruses

Secretory IgA in Intestinal Mucosal Secretions as an Adaptive Barrier against Microbial Cells

Perspectives on how mucosal immune responses, infections and gut microbiome shape IgA nephropathy and future therapies

Fantastic IgA plasma cells and where to find them

New concepts in the generation and functions of IgA

[Immunoglobulin A (IgA) and its cellular receptors: Recent advances and new pathogenetical hypothesis]

Structural Insights into Immunoglobulin M

Diversity and dynamism of IgA−microbiota interactions

Structural Insights into Secretory Immunoglobulin A and Its Interaction with a Pneumococcal Adhesin

Immunomodulatory and anti‐inflammatory properties of immunoglobulin G antibodies

Know your enemy or find your friend?-Induction of IgA at mucosal surfaces

Advancements in understanding the role of intestinal dysbacteriosis mediated mucosal immunity in IgA nephropathy

Re-thinking the functions of IgA(+) plasma cells